Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in Depressive Patients with Aberrant N100 Slope
NCT01357967Phase 4Unknown
- Sponsor
- Inje University
- Start
- May 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in major depressive disorder (MDD), sponsored by Inje University. Status: unknown.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01357967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357967.